Biotech · Private company
Galderma R&D
Track this companyFree. Adds Galderma R&D to your Dealase workspace and tells you when its record changes.
Clinical trials2515 recruiting or active
Pipeline programs16From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline16
- NemolizumabPhase 3 · Prurigo NodularisClinicalTrials.gov · fetched Nov 12, 2026
- NemolizumabPhase 3 · Moderate-to-Severe Atopic DermatitisClinicalTrials.gov · fetched Nov 12, 2026
- QM1114-DPPhase 3 · Glabellar Frown LinesClinicalTrials.gov · fetched Nov 12, 2026
- nemolizumabPhase 2 · Chronic Pruritus of Unknown OriginClinicalTrials.gov · fetched Nov 12, 2026
- NemolizumabPhase 2 · Dermatitis, AtopicClinicalTrials.gov · fetched Nov 12, 2026
- NemolizumabPhase 2 · Systemic SclerosisClinicalTrials.gov · fetched Nov 12, 2026
- Active Comparator: FDA approved dermal filler device (RHA 3)Skin ManifestationsClinicalTrials.gov · fetched Nov 12, 2026
- CetaphilPlaque PsoriasisClinicalTrials.gov · fetched Nov 12, 2026
- GAL1906WrinkleClinicalTrials.gov · fetched Nov 12, 2026
- GP0116Skin ManifestationsClinicalTrials.gov · fetched Nov 12, 2026
- Juvederm Voluma XCChin AugmentationClinicalTrials.gov · fetched Nov 12, 2026
- Restylane ContourTemporal HollowingClinicalTrials.gov · fetched Nov 12, 2026
- Restylane Lyft with LidocaineChin AugmentationClinicalTrials.gov · fetched Nov 12, 2026
- Sculptra AestheticNon-facial Skin Aesthetic ConditionsClinicalTrials.gov · fetched Nov 12, 2026
- Sculptra®Cheek WrinklesClinicalTrials.gov · fetched Nov 12, 2026
- Sculptra®Volume Deficiency in the Mid-FaceClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials25
- Impact of Dysport on PMFF Donor ScarPHASE4 · NOT_YET_RECRUITING · started Sep 14, 2026ClinicalTrials.gov NCT07720726 · fetched Nov 12, 2026
- Pharmacokinetics, Safety and Efficacy of Nemolizumab in Participants Aged 6 to 23 Months With Moderate-to Severe Atopic DermatitisPHASE2 · RECRUITING · started Jul 13, 2026ClinicalTrials.gov NCT07660835 · fetched Nov 12, 2026
- Study to Evaluate the Safety of Retreatment With Restylane® Lyft With Lidocaine for Augmentation of the Chin RegionNA · RECRUITING · started Jun 3, 2026ClinicalTrials.gov NCT07566286 · fetched Nov 12, 2026
- A Study of Nemolizumab for the Treatment of Adults With Systemic SclerosisPHASE2 · RECRUITING · started Feb 20, 2026ClinicalTrials.gov NCT07047690 · fetched Nov 12, 2026
- Treatment of Perioral Wrinkles Using Topical Poly-L-lactic Acid and Microneedling DevicePHASE4 · RECRUITING · started Nov 7, 2025ClinicalTrials.gov NCT07225348 · fetched Nov 12, 2026
- A Study to Characterize Human Skin Changes From Biostimulator Treatments Via Non-invasive ImagingNA · RECRUITING · started Oct 21, 2025ClinicalTrials.gov NCT07399028 · fetched Nov 12, 2026
- Proof of Concept Study to Assess the Pharmacokinetics/Pharmacodynamics of Nemolizumab in Adults With Chronic Pruritus of Unknown Origin (CPUO)PHASE2 · ACTIVE_NOT_RECRUITING · started Oct 20, 2025ClinicalTrials.gov NCT07074977 · fetched Nov 12, 2026
- A Clinical Study to Assess Histological Changes From Treatment of Poly L-lactic Acid Biostimulator on Women at Various Menopausal StagesNA · RECRUITING · started Aug 12, 2025ClinicalTrials.gov NCT07342400 · fetched Nov 12, 2026
- Real-world Experience on Using Nemolizumab in the Treatment of Moderate-to- Severe Prurigo Nodularis in AdultsRECRUITING · started Aug 11, 2025ClinicalTrials.gov NCT06988618 · fetched Nov 12, 2026
- Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & AdultsRECRUITING · started Jul 14, 2025ClinicalTrials.gov NCT06988605 · fetched Nov 12, 2026
- Investigating Age Dependence of Fibroblast and Extracellular Matrix Responses to Cross-linked Hyaluronic Acid Filler in Human SkinNA · ACTIVE_NOT_RECRUITING · started May 9, 2024ClinicalTrials.gov NCT06195605 · fetched Nov 12, 2026
- A Study to Assess Efficacy and Tolerability of Topical Skincare Products on Psoriasis PatientsPHASE4 · COMPLETED · started Apr 8, 2024ClinicalTrials.gov NCT06357221 · fetched Nov 12, 2026
- Study to Evaluate the Safety and Effectiveness of GP0116NA · ACTIVE_NOT_RECRUITING · started Apr 12, 2023ClinicalTrials.gov NCT05987163 · fetched Nov 12, 2026
- Safety and Effectiveness of Restylane Lyft With Lidocaine for Augmentation of the Chin Region to Improve the Chin ProfileNA · COMPLETED · started Mar 22, 2023ClinicalTrials.gov NCT05777759 · fetched Nov 12, 2026
- Effectiveness and Safety of Restylane Contour in the Treatment of Temple HollowingNA · COMPLETED · started Mar 14, 2023ClinicalTrials.gov NCT05691972 · fetched Nov 12, 2026
- Assess Aesthetic Improvement With QM1114-DP in Subjects With Moderate to Severe Lateral Canthal Lines and Glabellar LinesPHASE3 · COMPLETED · started Jan 23, 2023ClinicalTrials.gov NCT05148000 · fetched Nov 12, 2026
- Sculptra Chart ReviewCOMPLETED · started Jul 14, 2022ClinicalTrials.gov NCT05463978 · fetched Nov 12, 2026
- Pharmacokinetics, Safety and Efficacy of Nemolizumab in Participants With Moderate-to-Severe Atopic DermatitisPHASE2 · COMPLETED · started Jun 24, 2021ClinicalTrials.gov NCT04921345 · fetched Nov 12, 2026
- Main Study: A Study to Evaluate the Effectiveness and Safety of GAL1906 for Correction of Wrinkles in the décolletage Area Sub-study: A Follow-up Study to Evaluate the Analysis of Mammograms Following Treatment for Correction of Wrinkles in Décolletage Area in the Investigational Study 43USRV1906NA · COMPLETED · started Feb 8, 2021ClinicalTrials.gov NCT04717934 · fetched Nov 12, 2026
- Xerosis and Use of Topical MoisturizerNA · ACTIVE_NOT_RECRUITING · started Jan 21, 2021ClinicalTrials.gov NCT04341623 · fetched Nov 12, 2026
- A Long-term Study of Nemolizumab (CD14152) in Participants With Prurigo Nodularis (PN)PHASE3 · ACTIVE_NOT_RECRUITING · started Jan 11, 2021ClinicalTrials.gov NCT04204616 · fetched Nov 12, 2026
- Restylane Refyne for Correction of Horizontal Neck RhytidesNA · COMPLETED · started Aug 11, 2020ClinicalTrials.gov NCT04162496 · fetched Nov 12, 2026
- A Study to Assess Immunization Responses in Adult and Adolescent Participants With Moderate-to-Severe Atopic Dermatitis Treated With NemolizumabPHASE2 · COMPLETED · started Mar 5, 2020ClinicalTrials.gov NCT04365387 · fetched Nov 12, 2026
- Long-term Safety and Efficacy of Nemolizumab With Moderate-to-severe Atopic DermatitisPHASE3 · COMPLETED · started Dec 30, 2019ClinicalTrials.gov NCT03989206 · fetched Nov 12, 2026
- Defining the Skin and Blood Biomarkers of IchthyosisENROLLING_BY_INVITATION · started Jan 31, 2018ClinicalTrials.gov NCT03417856 · fetched Nov 12, 2026